A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

~88 mi. (Bornova, Turkey, +192 more cities)

Ege University Medicine of Faculty

ER Positive, +1 more biomarker

Breast Carcinoma

abemaciclib, +1 more drug

hormone therapy, +1 more type

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~88 mi. (Bornova, Turkey, +226 more cities)

Ege University Medicine of Faculty ( Site 0661)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

~88 mi. (Bornova, Turkey, +184 more cities)

Ege University Medicine of Faculty

RET Fusion

Non-Squamous Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

TAK-788 as First-line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

~88 mi. (Bornova, Turkey, +144 more cities)

Ege University Medical Faculty

EGFR Exon 20 Insertion

Non-Squamous Non-Small Cell Lung Carcinoma

mobocertinib

targeted therapy

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL) or Pancreatic Neuroendocrine Tumor (pNET) (MK-6482-015)

~88 mi. (Bornova, Turkey, +29 more cities)

Ege University Medicine of Faculty ( Site 0900)

Pancreatic Neuroendocrine Tumor, +1 more condition

belzutifan

targeted therapy

A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

~88 mi. (Bornova, Turkey, +21 more cities)

Ege University Medicine of Faculty ( Site 1105)

Classical Hodgkin Lymphoma, +1 more condition

pembrolizumab

immunotherapy

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

~89 mi. (İzmir, Turkey, +172 more cities)

Izmir Medical Park Hospital

RET Fusion

Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That Has Invaded the Muscle Wall of the Bladder and Who Cannot Get Cisplatin, a Type of Medicine Given to Treat Bladder Cancer.

~89 mi. (İzmir, Turkey, +137 more cities)

Local Institution

Bladder Urothelial Carcinoma

bempegaldesleukin, +2 more drugs

immunotherapy, +2 more types

Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)

~93 mi. (Balçova, Turkey, +16 more cities)

Dokuz Eylül Üniversitesi ( Site 5002)

Classical Hodgkin Lymphoma

BEACOPP regimen, +4 more drugs

chemotherapy, +1 more type